New study explores how Galaxy Watch technology could help track muscle health during GLP 1 therapy
Boston, Massachusetts, 1 June 2026 – Samsung is expanding its role in digital healthcare through a new research partnership with Massachusetts General Hospital, one of the leading medical institutions in the United States. The collaboration will study how wearable technology, including the Galaxy Watch, can help monitor patients using GLP 1 weight loss medications and support healthier long-term outcomes.
The research focuses on a growing concern surrounding GLP-1 medications, which are widely used for weight management and diabetes treatment. While these medicines have shown strong results in helping people lose weight, health experts have raised concerns about muscle mass loss that may occur during treatment. Researchers believe wearable technology could play an important role in helping patients and doctors monitor these changes more effectively.
Samsung and Massachusetts General Hospital will use the Galaxy Watch8 as part of a clinical study involving 100 adults who are beginning GLP-1 therapy. The study will compare patients using Galaxy Watch health tracking features with those receiving standard treatment guidance. Researchers aim to determine whether continuous health monitoring can help patients maintain muscle mass and develop healthier lifestyle habits during their weight loss journey.
The Galaxy Watch will collect important biometric information such as body composition, physical activity levels, heart rate, and other health indicators. These insights may help healthcare professionals gain a more complete understanding of how patients respond to treatment and make better-informed decisions throughout the process.
To ensure accuracy, researchers will also use advanced DXA scans, which are considered one of the most reliable methods for measuring body composition and muscle mass. The data gathered from both the smartwatch and medical scans will help determine whether wearable technology can support better health outcomes for people using GLP 1 medications.
Industry experts believe the partnership reflects a larger trend in healthcare, where consumer technology is increasingly being integrated into medical research and patient care. Wearable devices are no longer used only for fitness tracking. They are becoming valuable tools for monitoring health conditions, supporting preventive care, and improving patient engagement.
Samsung has been steadily expanding its healthcare initiatives through collaborations with hospitals, universities, and research institutions. The company has previously worked on studies related to sleep apnea detection, cardiovascular monitoring, and other health-focused innovations using Galaxy wearable devices. These efforts highlight Samsung’s broader strategy of positioning its wearable technology as part of the growing digital health ecosystem.
As demand for personalized healthcare solutions continues to grow, the combination of wearable technology, artificial intelligence, and real-time health monitoring is expected to play a larger role in medical treatment. Samsung’s latest partnership demonstrates how technology companies and healthcare providers are working together to improve patient care and create more data-driven health management solutions.
The study also highlights the increasing importance of digital health tools in addressing modern healthcare challenges. By exploring how wearable devices can support patients during weight loss treatment, Samsung and Massachusetts General Hospital are helping shape the future of connected healthcare and personalized wellness management.